bibliographicCitation |
Seki Y, Yamamoto N, Tamura Y, Goto Y, Shibata T, Tanioka M, Asahina H, Nokihara H, Yamada Y, Shimamoto T, Noguchi K, Tamura T. Phase I study for ridaforolimus, an oral mTOR inhibitor, in Japanese patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 2011 Dec 06;69(4):1099–105. doi: 10.1007/s00280-011-1788-4. |